REG - Competition and Mkts - Medivet/multiple independent veterinary businesses

LivanovaAnnouncement

02/06/2023 15:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230602:nRSB5271Ba&default-theme=true

RNS Number : 5271B  Competition and Markets Authority  02 June 2023

 

 

CMA to look at Medivet's undertakings offer in detail

 

 

Completed acquisitions by Medivet Group Limited (Medivet) of seventeen
independent veterinary businesses

 

On 2 June 2023, the CMA announced that it is or may be the case that each of
the following Mergers has resulted or may be expected to result in a
substantial lessening of competition within a market or markets in the United
Kingdom. Namely, Medivet's acquisitions of:

(a)   All Creatures Clinic Limited (All Creatures);

(b)   Barton Companion Animal Services Limited (Barton);

(c)   I T Kalogera (Holdings) Limited, including its subsidiary I T Kalogera
Limited (t/a Brockwell Vets) (Brockwell Vets);

(d)   The assets and business of the veterinary practice under the name
'Caddy Veterinary Surgery/Practice' (Caddy Country);

(e)   E Street Limited (t/a Elizabeth Street Veterinary Clinic) (Elizabeth
Street);

(f)    Ferring Street Vets Limited (Ferring Street);

(g)   Fitzalan House Veterinary Practice Limited (Fitzalan House);

(h)   The Hackney Vet Ltd (The Hackney Vet);

(i)    The assets and business of the veterinary practice under the name
Iffley Vets (Iffley Vets);

(j)    The Oxford Cat Clinic Limited (Oxford Cat Clinic);

(k)   The assets and businesses of the veterinary practices under the name
The Vet on Richmond Hill & The Vet in St Margaret's (The Vet on Richmond
Hill & St Margaret's); and

(l)    The Vet Station Limited (The Vet Station).

 

 

On 25 May 2023, Medivet Group Limited, Hecate Holdco Limited (UK), CVC Capital
Partners VIII (A) L.P., CVC Capital Partners VIII Associates L.P. and CVC
Capital Partners Investment Europe VIII L.P., being funds managed by CVC
Capital Partners VIII Limited (CVC Capital) (together, the Acquirer Group)
offered undertakings to the CMA. The CMA has considered the undertakings
offered and today announced that it considers that there are reasonable
grounds for believing that the undertakings offered in relation to each of the
acquisitions under investigation, or a modified version of them, might be
accepted by the CMA to remedy the substantial lessening of competition
identified by the CMA in these cases.

 

The CMA now has until 28 July 2023 to decide whether to accept the
undertaking, with the possibility to extend this timeframe to 25 September
2023 if it considers there are special reasons for doing so.

 

The text of this decision will be placed on the Competition and Markets
Authority's website at https://www.gov.uk/cma-cases
(https://www.gov.uk/cma-cases) as soon as is reasonably practical.

 

In the event of media enquiries please email Press@cma.gov.uk
(mailto:Press@cma.gov.uk) .

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MERFTMBTMTTMBTJ